Solid Biosciences
SLDB · NASDAQ
$6.40+$0.48 (+8.11%)TodayMarket closed ·
Prev close $5.92
EPS: actual vs estimate
Beat the estimate in 2 of the last 8 quarters, by 19.4% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.4776 | -$0.38 | +20.4% |
| Q1 FY26 | -$0.4422 | -$0.52 | −17.6% |
| Q4 FY25 | -$0.5292 | -$0.53 | −0.2% |
| Q3 FY25 | -$0.4475 | -$0.48 | −7.3% |
| Q2 FY25 | -$0.5142 | -$0.42 | +18.3% |
| Q1 FY25 | -$0.5669 | -$0.59 | −4.1% |
| Q4 FY24 | -$0.8223 | -$1.00 | −21.6% |
| Q3 FY24 | -$0.6809 | -$0.79 | −16.0% |
Earnings calls
- Citigroup’s Biopharma Back to School Summit 2026
- Goldman Sachs 47th Annual Global Healthcare Conference 2026
- Barclays 28th Annual Global Healthcare Conference
- Guggenheim Securities Emerging Outlook: Biotech Summit 2026
- 44th Annual J.P. Morgan Healthcare Conference
- Citi's Biopharma Back to School Conference
- Jefferies Global Healthcare Conference 2025
- Barclays 27th Annual Global Healthcare Conference 2025
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.